A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence

Trial Profile

A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2017

At a glance

  • Drugs Autologous muscle-derived stem cell therapy Cook MyoSite (Primary)
  • Indications Stress incontinence; Urinary incontinence
  • Focus Therapeutic Use
  • Acronyms IND2
  • Sponsors Cook MyoSite
  • Most Recent Events

    • 10 Jul 2017 Status changed from recruiting to active, no longer recruiting.
    • 07 Apr 2016 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019 as reported by ClinicalTrials.gov record.
    • 07 Apr 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top